‌

US Patent 7807392 Lung disease targets and uses thereof

Patent 7807392 was granted and assigned to Celera Corporation on October, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Celera Corporation

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

78073920

Patent Inventor Names

Aiqun Li0

Tao He0

Elizabeth Joseloff0

Bruno Domon0

Date of Patent

October 5, 2010

Patent Application Number

119052160

Date Filed

September 28, 2007

Patent Primary Examiner

‌

Larry Helms

Patent abstract

The present invention provides a method for diagnosing and detecting diseases associated with lung. The present invention provides one or more proteins or fragments thereof, peptides or nucleic acid molecules differentially expressed in lung cancer (LCAT) and antibodies binds to LCATs. The present invention provides that LCATs are used as targets for screening agents that modulates the LCAT activities. Further the present invention provides methods for treating diseases associated with lung.